ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000230826.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.010166443	Resistant
ENSG00000230826.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.003537371	Resistant